Search

Displaying results 2531 - 2540 of 10000 in total
  1. Drug

    Algestone

    go.drugbank.com/drugs/DB18000
    Experimental

    Synonyms: 16.alpha.,17-dihydroxyprogesterone, 16.alpha.,17-dihydroxypregn-4-ene-3,20-dione
  2. Indication

    Infection, Bacteroides

    go.drugbank.com/conditions/DBCOND0083355
    Drugs: Tetracycline
    Synonyms: Infection due to Bacteroides (disorder)
  3. Indication

    Tinea Cruris caused by Trichophyton rubrum

    go.drugbank.com/conditions/DBCOND0121740
    Drugs: Ketoconazole
    Synonyms: Tinea cruris due to Trichophyton rubrum (disorder)
  4. Indication

    Erythema Nodosum Leprosum

    go.drugbank.com/conditions/DBCOND0036567
    Drugs: Thalidomide
    Synonyms: Immune complex reaction co-occurrent and due to multibacillary leprosy, Immune complex reaction co-occurrent and due to multibacillary leprosy (disorder)
  5. Indication

    Balantidiasis

    go.drugbank.com/conditions/DBCOND0000922
    Drugs: Metronidazole
    Synonyms: Disease due to Balantidiidae (disorder)
  6. Indication

    Tachyarrhythmia caused by Digitalis intoxication

    go.drugbank.com/conditions/DBCOND0021763
    Drugs: Propranolol
    Synonyms: Toxicity to various agents
  7. Drug

    UCB7362

    go.drugbank.com/drugs/DB17096
    Experimental

    It has shown high potency in biochemical (IC<sub>50</sub> = 7 nM), _in vitro_ (_P. falciparum_ 3D7 lactate dehydrogenase growth inhibition assay IC<sub>50</sub> = 10 nM), and _in vivo_ (50 mg/kg dose … [A254222] Plasmepsins are aspartyl proteases produced by the malaria parasite _Plasmodium falciparum_, and PMX is considered to be essential for parasite egress and invasion.

  8. Drug

    Maltose

    go.drugbank.com/drugs/DB03323
    Investigational

    A dextrodisaccharide from malt and starch. It is used as a sweetening agent and fermentable intermediate in brewing (Grant &amp; Hackh's Chemical Dictionary, 5th ed).

    Products: MARTOS-10, CAPTOSA 10%
  9. Drug

    Polatuzumab vedotin

    go.drugbank.com/drugs/DB12240
    ApprovedInvestigational

    [L6658] Polatuzumab vedotin was granted accelerated FDA approval on June 10, 2019 [A254936] and was approved by Health Canada on July 9, 2020.[L44141] … ) that covalently attaches MMAE to polatuzumab.

    Categories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A Substrates
  10. Indication

    Proliferative Diabetic Retinopathy (PDR)

    go.drugbank.com/conditions/DBCOND0056889
    Drugs: Ranibizumab
    Synonyms: Retinopathy due to diabetes mellitus (disorder), Retinopathy co-occurrent and due to diabetes mellitus